ES8200560A1 - Un procedimiento para producir interferon de fibroblasto hu-mano - Google Patents

Un procedimiento para producir interferon de fibroblasto hu-mano

Info

Publication number
ES8200560A1
ES8200560A1 ES493849A ES493849A ES8200560A1 ES 8200560 A1 ES8200560 A1 ES 8200560A1 ES 493849 A ES493849 A ES 493849A ES 493849 A ES493849 A ES 493849A ES 8200560 A1 ES8200560 A1 ES 8200560A1
Authority
ES
Spain
Prior art keywords
interferon
passed
stage
continuous
high pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493849A
Other languages
English (en)
Other versions
ES493849A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8200560A1 publication Critical patent/ES8200560A1/es
Publication of ES493849A0 publication Critical patent/ES493849A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR INTERFERON DE FIBROBLASTO HUMANO. CONSISTE EN OBTENER LA PURIFICACION DEL INTERFERON MEDIANTE LA COMBINACION DE ETAPAS DE CROMATOGRAFIA DE AFINIDAD Y CROMATOGRAFIA DE LIQUIDO DE ALTA PRESION. EN LA PRIMERA ETAPA SE HACE PASAR UNA SOLUCION ACUOSA DE INTERFERON DE FIBROBLASTO HUMANO EN UN ESTADO IMPURO A TRAVES DE UNA COLUMNA DE CROMATOGRAFIA DE AFINIDAD, QUE ABSORBE EL INTERFERON Y SE ELUYE DE LA MISMA EN FRACCIONES SELECCIONADAS DE MAS PUREZA. ESTAS FRACCIONES SE HACEN PASAR EN UNA SEGUNDA ETAPA A TRAVES DE UNA O MAS COLUMNAS DE MATRIZ DE SILICE ENLAZADO A HIDROCARBURO CON TAMPON BAJO CONDICIONES DE CROMATOGRAFIA DE LIQUIDO DE ALTA PRESION, PARA ABSORVER Y ELUIR A CONTINUACION EL INTERFERON, OBTENIENDOLO COMO UNA SOLA CRESTA DISTINTIVA EN FRACCIONES SELECCIONADAS DE DICHO ELUATO EN EL ESTADO DE UNA PROTEINA HOMOGENEA.
ES493849A 1979-07-31 1980-07-30 Un procedimiento para producir interferon de fibroblasto hu-mano Granted ES493849A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (2)

Publication Number Publication Date
ES8200560A1 true ES8200560A1 (es) 1981-11-16
ES493849A0 ES493849A0 (es) 1981-11-16

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493849A Granted ES493849A0 (es) 1979-07-31 1980-07-30 Un procedimiento para producir interferon de fibroblasto hu-mano

Country Status (33)

Country Link
US (1) US5015730A (es)
JP (1) JPH02138226A (es)
AR (1) AR229931A1 (es)
AT (1) AT372387B (es)
AU (1) AU536274B2 (es)
CA (1) CA1146468A (es)
CH (1) CH648331A5 (es)
DE (1) DE3028919A1 (es)
DK (1) DK159825C (es)
DO (1) DOP1980002948A (es)
ES (1) ES493849A0 (es)
FI (1) FI70721C (es)
FR (1) FR2462167B1 (es)
GB (1) GB2055384B (es)
HK (1) HK40384A (es)
HU (1) HU185382B (es)
IE (1) IE50075B1 (es)
IL (1) IL60697A (es)
IT (1) IT1132269B (es)
KE (1) KE3364A (es)
LU (1) LU82673A1 (es)
MC (1) MC1337A1 (es)
MY (1) MY8500274A (es)
NL (1) NL8004361A (es)
NO (1) NO151158C (es)
NZ (1) NZ194495A (es)
PH (2) PH17738A (es)
PT (1) PT71625B (es)
RO (1) RO81474B (es)
SE (1) SE466290B (es)
YU (1) YU193480A (es)
ZA (1) ZA803943B (es)
ZW (1) ZW17980A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177213D1 (de) 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
DK1917276T3 (en) 2005-08-26 2018-05-07 Ares Trading Sa Process for Preparation of Glycosylated Interferon Beta
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
AU2008314687A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying Fc-fusion proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
AU536274B2 (en) 1984-05-03
DOP1980002948A (es) 1989-04-20
MY8500274A (en) 1985-12-31
DK328880A (da) 1981-02-01
FI70721B (fi) 1986-06-26
IL60697A (en) 1984-04-30
IL60697A0 (en) 1980-09-16
KE3364A (en) 1984-02-03
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
PH17738A (en) 1984-11-23
GB2055384B (en) 1983-08-10
ZW17980A1 (en) 1981-03-18
SE466290B (sv) 1992-01-27
AR229931A1 (es) 1984-01-31
IE801589L (en) 1981-01-31
IT8023801A0 (it) 1980-07-30
ZA803943B (en) 1981-06-24
NO802297L (no) 1981-02-02
DE3028919A1 (de) 1981-02-19
RO81474A (ro) 1983-04-29
NO151158C (no) 1985-02-20
AU6091480A (en) 1981-02-05
FI802400A7 (fi) 1981-02-01
DE3028919C2 (es) 1988-02-18
DK159825C (da) 1991-04-29
NZ194495A (en) 1984-07-31
ATA395080A (de) 1983-02-15
IT1132269B (it) 1986-07-02
JPH02138226A (ja) 1990-05-28
US5015730A (en) 1991-05-14
FR2462167B1 (fr) 1985-07-05
CA1146468A (en) 1983-05-17
LU82673A1 (fr) 1982-02-17
HK40384A (en) 1984-05-18
CH648331A5 (de) 1985-03-15
AT372387B (de) 1983-09-26
FR2462167A1 (fr) 1981-02-13
IE50075B1 (en) 1986-02-05
FI70721C (fi) 1986-10-06
PH18479A (en) 1985-07-18
ES493849A0 (es) 1981-11-16
MC1337A1 (fr) 1981-04-21
YU193480A (en) 1984-04-30
DK159825B (da) 1990-12-10
HU185382B (en) 1985-01-28
PT71625A (en) 1980-08-01
NO151158B (no) 1984-11-12
GB2055384A (en) 1981-03-04
RO81474B (ro) 1983-04-30
SE8005498L (sv) 1981-02-01

Similar Documents

Publication Publication Date Title
ES8100502A1 (es) Un procedimiento para purificar proteinas con pesos moleculares superiores a 12.000,en particular interferon
LU88122A1 (fr) Anticorps purifies specifiquement developpes contre le cdw52
DE3775360D1 (de) Hplc-kolonne.
ES8101384A1 (es) Procedimiento de preparacion de productos citotoxicos
ES148729U (es) Microscopia de bolsillo.
ES427365A1 (es) Un metodo de aislamiento de uno al menos de los factores decoagulacion de la sangre: fibrinogeno, factor viii antihe- mofilia y factor b.
ES393482A1 (es) Procedimiento para la separacion cromatografica de mezclas de varias sustancias.
ES2058908T3 (es) Procedimiento para la separacion y purificacion de sialil-transferasas.
ES2115622T5 (es) Clones moleculares de hiv-1 y usos de los mismos.
HK40384A (en) Homogeneous fibroblast interferon and method for manufacture thereof
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
CH408465A (de) Verfahren zur Herstellung von Kapillarsäulen für die Gaschromatographie
IT1088757B (it) Organo di diramazione per la commutazione dipassaggio del gas nelle colonne di distillazione capillari impiegato nella gascromatografia
MX167325B (es) Procedimiento para la purificacion de activador de plasminogeno (pa)
ES279485A1 (es) Un método de hidrolizar sulfuro de carbonilo gaseoso
SE7712071L (sv) Tymosin alfa Ÿ1
ES8404187A1 (es) Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo
FR1231830A (fr) Perfectionnements aux thermomètres à dilatation de liquide
BE614659A (fr) Perfectionnements relatifs aux circuits de fonctionnement des lampes fluorescentes à décharge
ES61102U (es) Soporte flexible para sombrillas
ES86514U (es) Instrumento para dibujo perfeccionado
ES86533U (es) Farola luminosa
ES98246U (es) Lámpara de mano perfeccionada
BE590438A (fr) Procédé destiné à la publicité, qui consiste à rendre transparent, à l'éclairage indirect, un écran opaque.
ES88606U (es) Abrazadera para muestrarios textiles